Showing results (1811-1820 of 2,006) with videos related to
Sort By:
Pageof 201
Immunology and Cell Biology|March 11, 2015
GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis modelRoselind S Lam, Neil M O'Brien-Simpson, John A Hamilton, et al.Bioorganic & Medicinal Chemistry Letters|June 22, 2014
Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moietiesMichael J Orwat, Jennifer X Qiao, Kan He, et al.Indian Journal of Ophthalmology|August 24, 2021
iStent versus iStent inject implantation combined with phacoemulsification in open angle glaucomaWesam Shamseldin Shalaby, Sophia S Lam, Amirmohsen Arbabi, et al.Nanomedicine (London, England)|June 2, 2026
A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancerAthira Narayan, Ryan C Leibrandt, Joyce S Lee, et al.Journal of Virology|January 14, 2011
Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factorPei-Ching Chang, Latricia D Fitzgerald, Datsun A Hsia, et al.Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor XaYun-Long Li, John M Fevig, Joseph Cacciola, et al.Journal of the American College of Cardiology|September 2, 2025
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-AnalysisBart J van Essen, Daan C H Ceelen, Wouter Ouwerkerk, et al.Scandinavian Journal of Rheumatology|February 6, 2010
Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosusC C Mok, W L Poon, J P S Lai, et al.Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Nonbenzamidine isoxazoline derivatives as factor Xa inhibitorsMimi L Quan, Christopher D Ellis, Ming Y He, et al.Lung Cancer (Amsterdam, Netherlands)|November 3, 2024
Treatment with trimetazidine dihydrochloride and lung cancer survival: Implications on metabolic re-programmingYap-Hang Chan, Cheng Yuen-Ting, Chun-Fung Sin, et al.Pageof 201